Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer

Record History

1. Minor Sep 15, 2026 Eligibility criteria expanded, about 16 words
2. Notable Mar 12, 2026 Primary completion date: Jan 2009 to Jan 19, 2011 Start date: Sep 2006 to Sep 25, 2009 · Completion date: Jul 2009 to Jan 19, 2011v4 Show all 3 changesShow less

   • Start date: Sep 2006 to Sep 25, 2009
   • Completion date: Jul 2009 to Jan 19, 2011
3. Minor Jul 20, 2012 Trial status: Active, Not Recruiting to Completed Study description shortened, about 8 wordsv3 Show all 2 changesShow less

   • Study description shortened, about 8 words

   See this version in full on ClinicalTrials.gov ↗

4. Minor May 22, 2009 Trial status: Recruiting to Active, Not Recruiting Primary completion date: Jan 2009 · Completion date: Sep 2008 to Jul 2009 · Interventions: Cyclophosphamide (Drug), Megestrol (Drug) to CYCLOPHOSPHAMIDE (Drug), MEGESTROL (Drug) · 3 morev2 Show all 7 changesShow less

   • Primary completion date: Jan 2009
   • Completion date: Sep 2008 to Jul 2009
   • Interventions: Cyclophosphamide (Drug), Megestrol (Drug) to CYCLOPHOSPHAMIDE (Drug), MEGESTROL (Drug)
   • Secondary endpoints revised (5)
   • Site details revised at 4 of 4 sites
   • Study arms: 0 to 2

   See this version in full on ClinicalTrials.gov ↗

5. Minor Jan 9, 2007 Study First Submitted

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.